EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2023
Disclosure of Share Capital and Voting Rights Outstanding
as of February 28, 2023
(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Charenton-le-Pont, France (March 17, 2023 - 6:00 pm) – As of February 28, 2023, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.
|February 28, 2023|
|Number of real voting rights (excluding treasury shares)||445,350,656|
|Theoretical number of voting rights (including treasury shares)||447,691,239|
It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained in article 23 of EssilorLuxottica’s by-laws2.
For further information, please consult the Prospectus which received Visa No. 18-460 from the AMF on September 28, 2018 and its Securities Note Supplement which received Visa No. 18-494 from the AMF on October 23, 2018, available on the website www.essilorluxottica.com.
1Including 3,006 shares delivered but not yet registered as of February 28, 2023.
2EssilorLuxottica’s by-laws are available on the Company’s website under the section Governance / Publications.
Upcoming Life Sciences Events
- March 2023
- Zurich: Swiss Nordic Bio 2023
- April 2023
- Basel: Swiss Biotech Day 2023
- London: BioTrinity 2023
Latest company news
Inventiva announces the schedule of publication and presentation of its 2022 Full-Year Financial Results
Curia Collaborates with Corning to Advance Biopharmaceutical Continuous-Flow Development and Manufacturing Programs
Resolutions from the Annual General Meeting of Novo Nordisk A/S